Furthermore, compared to healthy controls, serum levels of orexin‐A and TGF‐β were significantly lower in MS patients, whereas leptin levels were significantly higher (p 0.001, Figure 1). This evidence concerns the gene TGFB1 and myeloid sarcoma.